|     |   |
Investor Relations -> 2015 Press Releases
Receive E-mail AlertsE-mail Alerts
Keyword Search
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
07/07/15Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio
SHENZHEN, China, July 7, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. ("Dragonbio") for approximately US$72.6 million. Dragonbio is a domestic medical orthopedic-product provider that specializes in trauma, spine, joint and other surgical products. Prior to today's ... 
Printer Friendly Version
06/24/15Mindray Announces Formation of a Special Committee to Evaluate "Going Private" Proposal
SHENZHEN, China, June 24, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray" or the "Company") (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that its board of directors has formed a special committee (the "Special Committee") comprised of three independent directors of the Company, Mr. Ronald Ede, Mr. Kern Lim and Mr. Qiyao Wu, to consider the previously announced non-binding proposal (the "Proposal") received by the C... 
Printer Friendly Version
06/04/15Mindray Announces Receipt of "Going Private" Proposal at US$30.0 Per ADS or US$30.0 Per Ordinary Share
SHENZHEN, China, June 4, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray," NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter dated June 4, 2015 from Mr. Li Xiting, its Executive Chairman of the Board, President and Co-Chief Executive Officer, Mr. Xu Hang, its Chairman of the Board, and Mr. Cheng Minghe, its Co-Chief Executive ... 
Printer Friendly Version
05/11/15Mindray Announces First Quarter 2015 Financial Results
SHENZHEN, China, May 11, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2015. Highlights for First Quarter 2015 Net revenues increased 2.9% year-over-year to $272.5 million. China net revenues grew 5.3% year-over-year to $122.0 million, representing 44.8% of the company's total net... 
Printer Friendly Version
05/08/15Mindray Medical to Exhibit New Products at CMEF Spring 2015 in Shanghai
SHENZHEN, China, May 8, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it will exhibit more than 80 innovative products at the 73rd China International Medical Equipment Fair ("CMEF") in Shanghai, China between May 15 and May 18. Mindray will showcase the latest products from its three primary business segments, namely patient monitoring and life support, in-vi... 
Printer Friendly Version
04/21/15Mindray to Report 2015 First Quarter Financial Results on May 11, 2015
SHENZHEN, China, April 21, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the first quarter ended Mar 31, 2015 after the U.S. market closes on May 11, 2015. Mindray's management will hold an earnings conference call at 8:00 AM on May 12, 2015 U.S. Eastern Time (8:00 PM on May 12, 2015 Beijing/Hong Kong Time). Dial-in det... 
Printer Friendly Version
04/16/15Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
SHENZHEN, China, April 16, 2015 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that it has filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2014. An electronic version of Mindray's Annual Report on Form 20-F is available on Mindray's investor relations website at http://ir.mindray... 
Printer Friendly Version
03/09/15Mindray Announces 2014 Fourth Quarter and Full Year Results
SHENZHEN, China, March 9, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2014. Highlights for Fourth Quarter and Full Year 2014 Full year net revenues increased 9.0% year-over-year to $1.3 billion. China net revenues rose 10.1% to $606.7 million for the full year.... 
Printer Friendly Version
02/12/15Mindray to Report 2014 Fourth Quarter and Full Year Financial Results on Mar 9, 2015
SHENZHEN, China, Feb. 12, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its fourth quarter and full year financial results ended Dec 31, 2014 after the U.S. market closes on Mar 9, 2015. Mindray's management will hold an earnings conference call at 8:00 AM on Mar 10, 2015 U.S. Eastern Time (8:00 PM on Mar 10, 2015 Beijing/Hong Kong Time). Dial-i... 
Printer Friendly Version
01/12/15Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance
SHENZHEN, China, Jan. 12, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray," NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2014. The company also provided net revenues guidance for 2015. For the year ended December 31, 2014, Mindray expects net revenues to be approximately US$1,318 million, representing a year-over-year growth of approxim... 
Printer Friendly Version
01/06/15Mindray to Participate in Upcoming Investor Conferences and Events
SHENZHEN, China, Jan 6, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present in four upcoming investor conferences and events. Mr. Alex Lung, Mindray's Chief Financial Officer, will attend the 33rd Annual J.P. Morgan Healthcare Conference, which will be held on January 12-15, 2015 at the Westin St. Francis Hotel in San Francisco. Mr. Lung will present a... 
Printer Friendly Version